Detalhe da pesquisa
1.
Current perspectives on resistance to chimeric antigen receptor T-cell therapy and strategies to improve efficacy in B-cell lymphoma.
Eur J Haematol
; 112(2): 144-152, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987995
2.
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
Blood
; 137(5): 624-636, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32902645
3.
A unique hub-and-spoke model to optimize patient management in lymphoma using novel chimeric antigen receptor-T cell therapy in Southeast and South Asia.
Hematol Oncol
; 2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35951479
4.
CAR T Cell Therapy in Hematological Malignancies: Implications of the Tumor Microenvironment and Biomarkers on Efficacy and Toxicity.
Int J Mol Sci
; 23(13)2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805933
5.
A proposed predictive mathematical model for efficient T-cell collection by leukapheresis for manufacturing chimeric antigen receptor T cells.
Haematologica
; 108(11): 3131-3134, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165850
6.
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells.
Nat Biomed Eng
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834752
7.
Conjunctival T Cell Profile in Allogeneic Hematopoietic Stem Cell Transplant Patients after Instilling Topical Cyclosporine-A 0.1% Cationic Emulsion.
Ophthalmol Ther
; 12(3): 1547-1567, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856978
8.
Activated B cells suppress T-cell function through metabolic competition.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543374
9.
Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore's private insurance payer's perspective.
J Med Econ
; 24(1): 637-653, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904359